SNORD1C and colorectal carcinoma: For example, SNORA21, SNORA24, and SNORA42 are upregulated in CRC and promote tumor growth both in vivo and in vitro; SNORD1C maintains the stemness of CRC cells and resistance to the chemotherapeutic drug 5-FU by activating the Wnt pathway.